Disc Medicine, Inc. financial data

Symbol
IRON on Nasdaq
Location
Watertown, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2783% % 33%
Debt-to-equity 9% % 72%
Return On Equity -32% % -25%
Return On Assets -29% % -21%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37,750,162 shares 27%
Common Stock, Shares, Outstanding 35,006,636 shares 18%
Entity Public Float $983,000,000 USD 94%
Common Stock, Value, Issued $4,000 USD 33%
Weighted Average Number of Shares Outstanding, Basic 35,178,691 shares 18%
Weighted Average Number of Shares Outstanding, Diluted 35,178,691 shares 18%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $149,213,000 USD 58%
General and Administrative Expense $30,445,000 USD 54%
Operating Income (Loss) $203,602,000 USD -63%
Nonoperating Income (Expense) $22,941,000 USD 6.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $180,661,000 USD -75%
Income Tax Expense (Benefit) $449,000 USD 113%
Net Income (Loss) Attributable to Parent $181,110,000 USD -75%
Earnings Per Share, Basic -5 USD/shares -36%
Earnings Per Share, Diluted -5 USD/shares -36%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $140,664,000 USD -27%
Marketable Securities, Current $475,256,000 USD 61%
Cash, Cash Equivalents, and Short-term Investments $615,900,000 USD 26%
Assets, Current $627,168,000 USD 27%
Property, Plant and Equipment, Net $1,228,000 USD 1454%
Operating Lease, Right-of-Use Asset $1,220,000 USD -27%
Other Assets, Noncurrent $840,000 USD 256%
Assets $630,456,000 USD 27%
Accounts Payable, Current $7,268,000 USD 105%
Employee-related Liabilities, Current $9,000,000 USD 97%
Accrued Liabilities, Current $11,115,000 USD 102%
Liabilities, Current $26,744,000 USD 5%
Operating Lease, Liability, Noncurrent $1,373,000 USD -20%
Liabilities $57,065,000 USD 110%
Accumulated Other Comprehensive Income (Loss), Net of Tax $718,000 USD -3.1%
Retained Earnings (Accumulated Deficit) $449,655,000 USD -67%
Stockholders' Equity Attributable to Parent $573,391,000 USD 23%
Liabilities and Equity $630,456,000 USD 27%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $41,376,000 USD -23%
Net Cash Provided by (Used in) Financing Activities $244,251,000 USD 1436%
Net Cash Provided by (Used in) Investing Activities $67,000 USD -131%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 35,006,636 shares 18%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $69,758,000 USD -293%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $140,904,000 USD -27%
Interest Paid, Excluding Capitalized Interest, Operating Activities $698,000 USD
Deferred Tax Assets, Valuation Allowance $104,670,000 USD 69%
Deferred Tax Assets, Gross $105,136,000 USD 69%
Operating Lease, Liability $1,678,000 USD -20%
Payments to Acquire Property, Plant, and Equipment $851,000 USD 1170%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $181,133,000 USD -140%
Lessee, Operating Lease, Liability, to be Paid $2,167,000 USD -11%
Operating Lease, Liability, Current $656,000 USD 763%
Lessee, Operating Lease, Liability, to be Paid, Year Two $768,000 USD -9.6%
Lessee, Operating Lease, Liability, to be Paid, Year One $324,000 USD -62%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $489,000 USD 51%
Lessee, Operating Lease, Liability, to be Paid, Year Three $285,000 USD -61%
Deferred Tax Assets, Operating Loss Carryforwards $33,209,000 USD 37%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $389,000 USD
Additional Paid in Capital $1,022,324,000 USD 39%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $20,000 USD -23%
Deferred Tax Assets, Net of Valuation Allowance $466,000 USD -16%
Share-based Payment Arrangement, Expense $28,631,000 USD 99%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%